Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
about
Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphomaThe evolving role of response-adapted PET imaging in Hodgkin lymphomaThe role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseProgress and problems in the application of focused ultrasound for blood-brain barrier disruption.Hodgkin lymphoma, version 2.2015.Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacyRole of chemotherapy in Hodgkin's lymphoma.Role of Radiotherapy in Modern Treatment of Hodgkin's LymphomaDeclining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignanciesPrognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experienceTailored strategies for radiation therapy in classical Hodgkin's lymphoma.Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.The benefit of consolidation radiotherapy to initial disease bulk in patients with advanced Hodgkin's disease who achieved complete remission after standard chemotherapyTherapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country.Clinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary Care CentrePoint/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution.Hodgkin lymphoma: A clinicopathological and immunophenotypic study.Treatment results in advanced stage Hodgkin's lymphoma: a retrospective study.Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.Treatment outcome of limited stage Hodgkin's disease.ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineClassical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.Management of children with high-risk Hodgkin lymphoma.Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.Comparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment.Risk-adapted strategies for the treatment of Hodgkin lymphoma.PET-directed therapy in Hodgkin lymphoma: Ready for prime time?Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.Management of Hodgkins Lymphoma: ICMR Consensus Document.Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma.Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans.Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival.Managing advanced stage Hodgkin lymphoma.
P2860
Q24236589-B571C2FE-3E28-4D80-B286-B1C6E7A56AD0Q26750993-655C0F1B-492A-411E-BC47-4248A572A283Q26858893-6B3C46E6-3C64-48E4-B43F-A65BBDC885F8Q30487878-B9971974-3D36-4D7D-8715-1BA6542FB854Q30769157-894CB762-2CCB-4FF7-A1B2-B71B3B584FD4Q30937299-10960ABE-5F84-449F-AD8D-AF47C14D13FAQ33432165-3E9F9815-BFE9-4BEE-B7E6-217F6E1E946EQ33761103-765C4AE9-28FC-42EE-9D4B-80DE50E1D7B4Q34235785-8027611A-316D-4B17-A1F2-142BAA33DB25Q34473445-5B4F30D8-51CD-4F9C-ADDD-5834B9F9DC27Q34495333-FAAB3679-8BC7-4B55-B468-8C11F332E4D1Q34590943-CD6C5F21-2C6E-468E-9B4C-71C040E1D101Q34610653-17083AC9-A873-498C-814F-E78D437E54C0Q34617599-F5D19601-4D57-4DB6-BCE0-8BCADE4F4886Q35219755-8296F2EC-9507-4B8E-A0FF-9D256601B5AAQ36135751-9078C7FC-750E-40E2-BE50-6D2704A58D26Q36151188-501F418B-E842-4433-A5FC-8198229587CCQ36343717-52A10875-4017-49FD-93CA-3D09C8C7E05CQ36440046-1AF2C82A-AD0D-4AA9-AC68-5B1D2BFF411FQ36458013-8A2BF5ED-2E65-4F17-B9A5-AEC94CE6F754Q36696395-428E3245-F562-4B46-B4D9-336B2CF43470Q37091269-7242E3FE-776F-4178-9EA0-3E98F278C572Q37383554-AB6DCD9E-1184-44C9-9A0E-C39BE30D1E6FQ37447063-EC592570-A5F7-4BB1-BCDD-33D01506DA9BQ37598106-D2F79FB9-9908-4C6F-821D-472EE628178EQ37644025-BD7A9103-C115-49E5-9ED5-357BCAF02673Q37832198-EEF3E8D1-B4E0-48F7-BEBA-124F87E060E5Q37970408-B93C669D-FCA0-4EEC-BE30-C4932F4AA9A5Q38095513-ECC190FA-9EA9-44A7-8A74-8A40CB5C086FQ38285777-2528F6F6-F039-4FC5-85EE-8AE3E25C351AQ38591137-77E824D5-ABD6-4786-990D-A8B02D4F73BEQ38608555-282C6466-189D-4CB6-8702-D0D55E96412AQ38817696-B9C97A40-794B-453C-9538-706CD41B3F9EQ39208309-7896B3C0-2358-40C3-8BA0-79E798D79460Q39658515-EFE60E7F-355D-497A-9D9D-E0BCD5D62EC4Q40040274-F2B66C56-6ACC-4FC2-93DE-C4D50A3D0EC7Q40044179-97AB3330-E1C1-4348-A1B4-E8109145491DQ40177374-84515FCC-55CC-44BE-AE88-1D1F1A456680Q41335670-C2EED2CE-6FE9-4DEA-B6F2-9571D008D78BQ42423722-896E2DA0-6696-4DE1-97F2-5B3F1E1CFB13
P2860
Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Consolidation radiation after ...... chemotherapy: is there a need?
@ast
Consolidation radiation after ...... chemotherapy: is there a need?
@en
Consolidation radiation after ...... chemotherapy: is there a need?
@nl
type
label
Consolidation radiation after ...... chemotherapy: is there a need?
@ast
Consolidation radiation after ...... chemotherapy: is there a need?
@en
Consolidation radiation after ...... chemotherapy: is there a need?
@nl
prefLabel
Consolidation radiation after ...... chemotherapy: is there a need?
@ast
Consolidation radiation after ...... chemotherapy: is there a need?
@en
Consolidation radiation after ...... chemotherapy: is there a need?
@nl
P2093
P356
P1476
Consolidation radiation after ...... chemotherapy: is there a need?
@en
P2093
K A Dinshaw
M A Muckaden
T K Saikia
P356
10.1200/JCO.2004.01.021
P407
P577
2003-12-02T00:00:00Z